Relationships between biomarkers and left ventricular filling pressures at rest and during exercise in patients after myocardial infarction

Journal of Cardiac Failure

Volumn 20, Issue 12, 2014, Pages 959-967

  Andersen, Mads J ^a,b   Ersbøll, Mads ^a   Bro Jeppesen, John ^a   Møller, Jacob E ^a   Hassager, Christian ^a   Køber, Lars ^a   Borlaug, Barry A ^b   Goetze, Jens P ^c   Gustafsson, Finn ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b MAYO CLINIC   (United States)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Acute myocardial infarction; biomarkers; exercise testing; hemodynamics

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; COPEPTIN; GALECTIN 3; PROADRENOMEDULLIN; ADRENOMEDULLIN;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD LEVEL; EXERCISE; EXERCISE TEST; FEMALE; HEART CATHETERIZATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FILLING PRESSURE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PULMONARY ARTERY OCCLUSION PRESSURE; REST; AGED; BLOOD; COMPARATIVE STUDY; HEART VENTRICLE PRESSURE; LUNG WEDGE PRESSURE; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGIC MONITORING; PHYSIOLOGY; PROCEDURES; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

ADRENOMEDULLIN; AGED; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIAC CATHETERIZATION; EXERCISE TEST; FEMALE; GALECTIN 3; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; MYOCARDIAL INFARCTION; PROGNOSIS; PULMONARY WEDGE PRESSURE; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; VENTRICULAR PRESSURE;

EID: 84920051526     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2014.09.012     Document Type: Article

References (36)

1. W. Shell, T. Peter, D. Mickle, J.S. Forrester, and H.J. Swan Prognostic implications of reduction of left ventricular filling pressure in early transmural acute myocardial infarction Am Heart J 102 3 Pt 1 1981 335 340
2. D. Planer, R. Mehran, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, and B.R. Brodie Prognostic utility of left ventricular end-diastolic pressure in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention Am J Cardiol 108 2011 1068 1074
3. S.R. Ommen, R.A. Nishimura, C.P. Appleton, F.A. Miller, J.K. Oh, and M.M. Redfield Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study Circulation 102 2000 1788 1794
4. S.F. Nagueh, K.J. Middleton, H.A. Kopelen, W.A. Zoghbi, and M.A. Quinones Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures J Am Coll Cardiol 30 1997 1527 1533
5. M.T. Maeder, B.R. Thompson, H.-P. Brunner-La Rocca, and D.M. Kaye Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction J Am Coll Cardiol 56 2010 855 863
6. W.J. Paulus, C. Tschope, J.E. Sanderson, C. Rusconi, F.A. Flachskampf, and F.E. Rademakers How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology Eur Heart J 28 2007 2539 2550
7. G.S. Hillis, J.E. Møller, P.A. Pellikka, B.J. Gersh, R.S. Wright, and S.R. Ommen Noninvasive estimation of left ventricular filling pressure by E/e′ is a powerful predictor of survival after acute myocardial infarction J Am Coll Cardiol 43 2004 360 367
8. J.E. Møller, G.A. Whalley, F.L. Dini, R.N. Doughty, G.D. Gamble, and A.L. Klein Independent prognostic importance of a restrictive left ventricular filling pattern after myocardial infarction: an individual patient meta-analysis: Meta-Analysis Research Group in Echocardiography Acute Myocardial Infarction Circulation 117 2008 2591 2598
9. R. Beinart, V. Boyko, E. Schwammenthal, R. Kuperstein, A. Sagie, and H. Hod Long-term prognostic significance of left atrial volume in acute myocardial infarction J Am Coll Cardiol 44 2004 327 334
10. G.A. Whalley, S.P. Wright, A. Pearl, G.D. Gamble, H.J. Walsh, and M. Richards Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community Eur Heart J 29 2008 509 516
11. J.E. Moller, P.A. Pellikka, G.S. Hillis, and J.K. Oh Prognostic importance of diastolic function and filling pressure in patients with acute myocardial infarction Circulation 114 2006 438 444
12. M.J. Andersen, M. Ersboll, F. Gustafsson, A. Axelsson, C. Hassager, and L. Kober Exercise-induced changes in left ventricular filling pressure after myocardial infarction assessed with simultaneous right heart catheterization and Doppler echocardiography Int J Cardiol 168 2013 2803 2810
13. M.J. Andersen, M. Ersboll, A. Axelsson, F. Gustafsson, C. Hassager, and L. Kober Sildenafil and diastolic dysfunction after acute myocardial infarction in patients with preserved ejection fraction: the Sildenafil and Diastolic Dysfunction After Acute Myocardial Infarction (SIDAMI) trial Circulation 127 2013 1200 1208
14. B.A. Borlaug, R.A. Nishimura, P. Sorajja, C.S. Lam, and M.M. Redfield Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction Circ Heart Fail 3 2010 588 595
15. M.J. Andersen, M. Ersboll, J. Bro-Jeppesen, F. Gustafsson, C. Hassager, and L. Kober Exercise hemodynamics in patients with and without diastolic dysfunction and preserved ejection fraction after myocardial infarction Circ Heart Fail 5 2012 444 451
16. M. Penicka, J. Bartunek, H. Trakalova, H. Hrabakova, M. Maruskova, and J. Karasek Heart failure with preserved ejection fraction in outpatients with unexplained dyspnea: a pressure-volume loop analysis J Am Coll Cardiol 55 2010 1701 1710
17. T.G. Flynn, M.L. de Bold, and A.J. de Bold The amino acid sequence of an atrial peptide with potent diuretic and natriuretic properties Biochem Biophys Res Commun 117 1983 859 865
18. Y. Iwanaga, I. Nishi, S. Furuichi, T. Noguchi, K. Sase, and Y. Kihara B-type natriuretic peptide strongly reflects diastolic wall stress in patients with chronic heart failure: comparison between systolic and diastolic heart failure J Am Coll Cardiol 47 2006 742 748
19. R.M. Lang, M. Bierig, R.B. Devereux, F.A. Flachskampf, E. Foster, and P.A. Pellikka Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology J Am Soc Echocardiog 18 2005 1440 1463
20. S.F. Nagueh, C.P. Appleton, T.C. Gillebert, P.N. Marino, J.K. Oh, and O.A. Smiseth Recommendations for the evaluation of left ventricular diastolic function by echocardiography J Am Soc Echocardiogr 22 2009 107 133
21. L.J. Sokoll, H. Baum, P.O. Collinson, E. Gurr, M. Haass, and H. Luthe Multicenter analytical performance evaluation of the Elecsys proBNP assay Clin Chem Lab Med 42 2004 965 972
22. D. Terzic, A. Johansson-Fallgren, O. Ragnarsson, J. Goetze, and O. Hammarsten Evaluation of a sensitive copeptin assay for clinical measurement Open Clin Chem J 5 2012 21 26
23. I. Hunter, U. Alehagen, U. Dahlstrom, J.F. Rehfeld, D.L. Crimmins, and J.P. Goetze N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification Clin Chem 57 2011 1327 1330
24. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
25. Food and Drug Administration Galectin-3 assay Available at: http://www.accessdata.fda.gov/cdrh-docs/reviews/K093758.pdf 2010 Accessed September 19, 2014
26. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
27. R.A. de Boer, A.A. Voors, P. Muntendam, W.H. van Gilst, and D.J. van Veldhuisen Galectin-3: a novel mediator of heart failure development and progression Eur J Heart Fail 11 2009 811 817
28. M. Jougasaki, and J.C. Burnett Jr. Adrenomedullin: potential in physiology and pathophysiology Life Sci 66 2000 855 872
29. Y. Xue, P. Taub, N. Iqbal, A. Fard, P. Clopton, and A. Maisel Mid-region pro-adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long-term mortality in stable outpatients with heart failure Eur J Heart Fail 15 2013 1343 1349
30. V. Wenzel, A.C. Krismer, H.R. Arntz, H. Sitter, K.H. Stadlbauer, and K.H. Lindner A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation N Engl J Med 350 2004 105 113
31. P.S. Pang, M.A. Konstam, H.B. Krasa, K. Swedberg, F. Zannad, and J.E. Blair Effects of tolvaptan on dyspnoea relief from the EVEREST trials Eur Heart J 30 2009 2233 2240
32. M.M. Redfield, H.H. Chen, B.A. Borlaug, M.J. Semigran, K.L. Lee, and G. Lewis Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial JAMA 309 2013 1268 1277
33. S. Yusuf, M.A. Pfeffer, K. Swedberg, C.B. Granger, P. Held, and J.J. McMurray Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved trial Lancet 362 2003 777 781
34. B.M. Massie, P.E. Carson, J.J. McMurray, M. Komajda, R. McKelvie, and M.R. Zile Irbesartan in patients with heart failure and preserved ejection fraction N Engl J Med 359 2008 2456 2467
35. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, and J. Taylor The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur Heart J 27 2006 2338 2345
36. F. Edelmann, R. Wachter, A.G. Schmidt, E. Kraigher-Krainer, C. Colantonio, and W. Kamke Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial JAMA 309 2013 781 791